ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD Market Closed
Market Cap: 107.5m AUD

Wall Street
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.135 AUD with a low forecast of 0.091 AUD and a high forecast of 0.179 AUD.

Lowest
Price Target
0.091 AUD
72% Upside
Average
Price Target
0.135 AUD
155% Upside
Highest
Price Target
0.179 AUD
237% Upside
ImpediMed Ltd Competitors:
Price Targets
NYXH
Nyxoah SA
98% Upside
OBI
Ondine Biomedical Inc
323% Upside
AXGN
AxoGen Inc
85% Upside
IDXX
IDEXX Laboratories Inc
4% Downside
OPTOMED
Optomed Oyj
18% Upside
DIA
DiaSorin SpA
21% Upside
338220
Vuno Inc
99% Upside
2235
MicroTech Medical Hangzhou Co Ltd
10% Downside

Revenue
Forecast

Revenue Estimate
ImpediMed Ltd

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 7%. The projected CAGR for the next 3 years is 63%.

7%
Past Growth
63%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPD's stock price target?
Price Target
0.135 AUD

According to Wall Street analysts, the average 1-year price target for IPD is 0.135 AUD with a low forecast of 0.091 AUD and a high forecast of 0.179 AUD.

What is ImpediMed Ltd's Revenue forecast?
Projected CAGR
63%

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 7%. The projected CAGR for the next 3 years is 63%.

Back to Top